| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.012 | 0.9 |